Recombinant Anti-CD19 × Anti-CD64 Bi-specific T-cell engagers (BsFab) (CAT#: BSAB-L024)
Recombinant Anti-CD19 & Anti-CD64 Bispecific Antibody (BsFab) is composed of the Fab of the anti-CD19 monoclonal antibody and Fab of an antibody specific for CD64. A stable thioether linkage is formed between the two Fab. The bispecific antibody is somewhat smaller than a whole IgG, and therefore it clears from the blood naturally at a faster rate. It was designed for the treatment of non-Hodgkin's lymphoma or chronic lymphocytic leukemia.
Specific Inquiry
Specifications
- Target
- CD19 & CD64
- Type
- BsFab
- Species Reactivity
- Human
- Target 1
- CD19
- Host Species 1
- Mouse
- Target 2
- CD64
- Host Species 2
- Humanized
- Related Disease
- Non-Hodgkin's lymphoma, chronic lymphocytic leukemia
Target
- Target 1
- CD19
- Gene ID
- 930
- UniProt ID
- P15391
- Alternative Names
- B4; CVID3
- Target 2
- CD64
- Gene ID
- 2209
- UniProt ID
- P12314
- Alternative Names
- CD64; FCRI; CD64A; IGFR1
Downloads
Download resources about recombinant antibody development and antibody engineering to boost your research.
Customer Reviews and Q&As
There are currently no Customer reviews or questions for BSAB-L024. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
Send Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.